Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides:: a comparative study

被引:196
|
作者
El-Andaloussi, Samir
Jarver, Peter [1 ]
Johansson, Henrik J.
Langel, Ulo
机构
[1] Stockholm Univ, Dept Neurochem, S-16091 Stockholm, Sweden
[2] Univ Tartu, Inst Technol, Lab Mol Biotechnol, EE-50090 Tartu, Estonia
关键词
cell-penetrating peptide; cytotoxicity; delivery vector; penetratin; transactivator of transcription (Tat); transport;
D O I
10.1042/BJ20070507
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of CPPs (cell-penetrating peptides) as delivery vectors for bioactive molecules has been an emerging field since 1994 when the first CPP, penetratin, was discovered. Since then, several CPPs, including the widely used Tat (transactivator of transcription) peptide, have been developed and utilized to translocate a wide range of compounds across the plasma membrane of cells both in vivo and in vitro. Although the field has emerged as a possible future candidate for drug delivery, little attention has been given to the potential toxic side effects that these peptides might exhibit in cargo delivery. Also, no comprehensive study has been performed to evaluate the relative efficacy of single CPPs to convey different cargos. Therefore we selected three of the major CPPs, penetratin, Tat and transportan 10, and evaluated their ability to deliver commonly used cargos, including fluoresceinyl moiety, double-stranded DNA and proteins (i.e. avidin and streptavidin), and studied their effect on membrane integrity and cell viability. Our results demonstrate the unfeasibility to use the translocation efficacy of fluorescein moiety as a gauge for CPP efficiency, since the delivery properties are dependent on the cargo used. Furthermore, and no less importantly, the toxicity of CPPs depends heavily on peptide concentration, cargo molecule and coupling strategy.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 50 条
  • [41] Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides
    Nhan, Nguyen Thi Thanh
    Maidana, Daniel E.
    Yamada, Kaori H.
    CELLS, 2023, 12 (07)
  • [42] Intracellular delivery of pharmaceutical nanocarriers by cell-penetrating peptides
    Torchilin, Vladimir
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [43] In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides
    Moulton, Hong M.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (16) : 2963 - 2969
  • [44] Cell-Penetrating Peptides: Emerging Tools for mRNA Delivery
    Yokoo, Hidetomo
    Oba, Makoto
    Uchida, Satoshi
    PHARMACEUTICS, 2022, 14 (01)
  • [45] Cell-Penetrating Peptides: Efficient Vectors for Vaccine Delivery
    Yang, Jieru
    Luo, Yacheng
    Shibu, Mohini Anjna
    Toth, Istvan
    Skwarczynski, Mariusz
    CURRENT DRUG DELIVERY, 2019, 16 (05) : 430 - 443
  • [46] Cell-penetrating peptides as delivery vehicles for biology and medicine
    Stewart, Kelly M.
    Horton, Kristin L.
    Kelley, Shana O.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2008, 6 (13) : 2242 - 2255
  • [47] Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals
    Kristensen, Mie
    Nielsen, Hanne Morck
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (02) : 99 - 106
  • [48] Cell-penetrating peptides: tools for intracellular delivery of therapeutics
    S. Deshayes
    M. C. Morris
    G. Divita
    F. Heitz
    Cellular and Molecular Life Sciences CMLS, 2005, 62 : 1839 - 1849
  • [49] Cell-penetrating peptides in the intracellular delivery of viral nanoparticles
    Hejtmankova, Alzbeta
    Vanova, Jana
    Spanielova, Hana
    HORMONES, REGULATORS AND VIRUSES, 2021, 117 : 47 - 76
  • [50] Cell-penetrating Peptides as Versatile Vehicles for Oligonucleotide Delivery
    Margus, Helerin
    Padari, Kaert
    Pooga, Margus
    MOLECULAR THERAPY, 2012, 20 (03) : 525 - 533